WQ
CATX icon

Wealth Quarterback’s Perspective Therapeutics CATX Stock Holding History

Wealth Quarterback’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Hold
13
– – ﹤0.01% 768
2021
Q2 		$1K Buy
+13
New +$114 ﹤0.01% 788
2020
Q2 		– Sell
-13
Closed -$70 – 202
2020
Q1 		$70 Hold
13
– – ﹤0.01% 942
2019
Q4 		$83 Buy
+13
New +$57 ﹤0.01% 979

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HPWM
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealth Quarterback's CATX Position: Q3 2021 in Review

Wealth Quarterback held its Perspective Therapeutics (CATX) position steady in Q3 2021 at 13 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Wealth Quarterback first reported a position in CATX in Q4 2019 and has held it in 4 quarters since. 43 funds tracked by Wall St. Rank hold CATX as of Q3 2021.

  • Wealth Quarterback held 13 shares of Perspective Therapeutics worth $1K as of Q3 2021.
  • Wealth Quarterback left its Perspective Therapeutics share count unchanged in Q3 2021.
  • Perspective Therapeutics made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #768 holding.
  • Wealth Quarterback first reported a position in Perspective Therapeutics in Q4 2019 and has held it in 4 quarters since.
  • 43 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.